(WTW) Willis Towers Watson - Overview
Stock: Insurance, Benefits, Retirement, Risk, Consulting
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.12% |
| Yield on Cost 5y | 1.74% |
| Yield CAGR 5y | 5.07% |
| Payout Consistency | 97.5% |
| Payout Ratio | 40.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 22.8% |
| Relative Tail Risk | -10.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.01 |
| Alpha | -4.15 |
| Character TTM | |
|---|---|
| Beta | 0.358 |
| Beta Downside | 0.483 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.14% |
| CAGR/Max DD | 0.60 |
Description: WTW Willis Towers Watson December 17, 2025
Willis Towers Watson PLC (WTW) is a global advisory, broking, and solutions firm organized into two main segments: Health, Wealth & Career and Risk & Broking. It delivers consulting, plan-design and administration services for employee health and benefits, pension and retirement solutions, and provides actuarial, investment-management, and change-management support for corporate clients.
In addition, the company offers risk-advisory and insurance-broking across property & casualty, aerospace, construction, marine, and specialty lines, complemented by data-analytics platforms, capital-modeling tools, and outsourcing services. The business is heavily exposed to corporate benefit spending trends and to the low-interest-rate environment that pressures pension funding and insurance capital requirements.
Key recent metrics: FY 2023 revenue of $10.3 billion, operating margin of ~15 %, and a 6 % year-over-year increase in consulting-services revenue driven by heightened demand for talent-management solutions. The firm’s growth is also linked to macro drivers such as rising employer investment in employee well-being programs and the ongoing regulatory tightening of solvency standards in the insurance sector.
For a deeper dive into how these dynamics translate into valuation insights, you may find ValueRay’s analytical framework worth exploring.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 2.12b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 1.58 > 1.0 |
| NWC/Revenue: 14.05% < 20% (prev 18.13%; Δ -4.08% < -1%) |
| CFO/TA 0.06 > 3% & CFO 1.60b > Net Income 2.12b |
| Net Debt (4.02b) to EBITDA (3.37b): 1.19 < 3 |
| Current Ratio: 1.10 > 1.5 & < 3 |
| Outstanding Shares: last quarter (100.0m) vs 12m ago -1.96% < -2% |
| Gross Margin: 43.38% > 18% (prev 0.52%; Δ 4285 % > 0.5%) |
| Asset Turnover: 35.92% > 50% (prev 36.10%; Δ -0.19% > 0%) |
| Interest Coverage Ratio: 11.36 > 6 (EBITDA TTM 3.37b / Interest Expense TTM 260.0m) |
Altman Z'' 0.81
| A: 0.05 (Total Current Assets 14.62b - Total Current Liabilities 13.24b) / Total Assets 27.44b |
| B: -0.02 (Retained Earnings -593.0m / Total Assets 27.44b) |
| C: 0.11 (EBIT TTM 2.95b / Avg Total Assets 27.30b) |
| D: -0.17 (Book Value of Equity -3.30b / Total Liabilities 19.63b) |
| Altman-Z'' Score: 0.81 = B |
Beneish M -2.66
| DSRI: 1.19 (Receivables 2.52b/2.12b, Revenue 9.81b/9.81b) |
| GMI: 1.21 (GM 43.38% / 52.41%) |
| AQI: 0.99 (AQ_t 0.42 / AQ_t-1 0.43) |
| SGI: 1.00 (Revenue 9.81b / 9.81b) |
| TATA: 0.02 (NI 2.12b - CFO 1.60b) / TA 27.44b) |
| Beneish M-Score: -2.66 (Cap -4..+1) = A |
What is the price of WTW shares?
Over the past week, the price has changed by +3.96%, over one month by -1.80%, over three months by +2.72% and over the past year by +2.10%.
Is WTW a buy, sell or hold?
- StrongBuy: 8
- Buy: 5
- Hold: 4
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the WTW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 369.1 | 11.8% |
| Analysts Target Price | 369.1 | 11.8% |
| ValueRay Target Price | 359.6 | 9% |
WTW Fundamental Data Overview February 03, 2026
P/E Forward = 16.3934
P/S = 3.1578
P/B = 3.9298
P/EG = 1.08
Revenue TTM = 9.81b USD
EBIT TTM = 2.95b USD
EBITDA TTM = 3.37b USD
Long Term Debt = 4.76b USD (from longTermDebt, last quarter)
Short Term Debt = 673.0m USD (from shortTermDebt, last quarter)
Debt = 5.91b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.02b USD (from netDebt column, last quarter)
Enterprise Value = 34.95b USD (30.97b + Debt 5.91b - CCE 1.93b)
Interest Coverage Ratio = 11.36 (Ebit TTM 2.95b / Interest Expense TTM 260.0m)
EV/FCF = 21.42x (Enterprise Value 34.95b / FCF TTM 1.63b)
FCF Yield = 4.67% (FCF TTM 1.63b / Enterprise Value 34.95b)
FCF Margin = 16.64% (FCF TTM 1.63b / Revenue TTM 9.81b)
Net Margin = 21.58% (Net Income TTM 2.12b / Revenue TTM 9.81b)
Gross Margin = 43.38% ((Revenue TTM 9.81b - Cost of Revenue TTM 5.55b) / Revenue TTM)
Gross Margin QoQ = 38.24% (prev 35.91%)
Tobins Q-Ratio = 1.27 (Enterprise Value 34.95b / Total Assets 27.44b)
Interest Expense / Debt = 1.10% (Interest Expense 65.0m / Debt 5.91b)
Taxrate = 20.10% (77.0m / 383.0m)
NOPAT = 2.36b (EBIT 2.95b * (1 - 20.10%))
Current Ratio = 1.10 (Total Current Assets 14.62b / Total Current Liabilities 13.24b)
Debt / Equity = 0.76 (Debt 5.91b / totalStockholderEquity, last quarter 7.74b)
Debt / EBITDA = 1.19 (Net Debt 4.02b / EBITDA 3.37b)
Debt / FCF = 2.46 (Net Debt 4.02b / FCF TTM 1.63b)
Total Stockholder Equity = 7.98b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.75% (Net Income 2.12b / Total Assets 27.44b)
RoE = 26.53% (Net Income TTM 2.12b / Total Stockholder Equity 7.98b)
RoCE = 23.19% (EBIT 2.95b / Capital Employed (Equity 7.98b + L.T.Debt 4.76b))
RoIC = 17.76% (NOPAT 2.36b / Invested Capital 13.29b)
WACC = 6.22% (E(30.97b)/V(36.88b) * Re(7.24%) + D(5.91b)/V(36.88b) * Rd(1.10%) * (1-Tc(0.20)))
Discount Rate = 7.24% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -1.94%
[DCF Debug] Terminal Value 87.29% ; FCFF base≈1.45b ; Y1≈1.79b ; Y5≈3.05b
Fair Price DCF = 795.4 (EV 80.18b - Net Debt 4.02b = Equity 76.16b / Shares 95.7m; r=6.22% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -19.22 | EPS CAGR: -46.35% | SUE: -4.0 | # QB: 0
Revenue Correlation: 13.61 | Revenue CAGR: -4.38% | SUE: 0.08 | # QB: 0
EPS next Quarter (2026-03-31): EPS=3.67 | Chg30d=+0.025 | Revisions Net=-3 | Analysts=9
EPS next Year (2026-12-31): EPS=19.32 | Chg30d=+0.097 | Revisions Net=-2 | Growth EPS=+13.9% | Growth Revenue=+8.0%